State anesthesia committee reviews complaint data, agrees to publish de‑identified charts and pursue clearer consult guidance

The Anesthesia Committee of the Texas State Board of Dental Examiners reviewed an annual spreadsheet of anesthesia‑related disciplinary data and agreed to make de‑identified charts available on the agency website as required by board rule.

The report, prepared by staff member Matt Matthews, covered one year of cases and found 138 anesthesia‑related instances in the agency’s complaint dataset. Matthews told the committee that while roughly 67 percent of disciplinary cases included some reference to anesthesia, only about 5 percent (seven cases) listed anesthesia as being associated with the complainant’s allegations. "So only about 5 percent of those cases — anesthesia was associated with the complaint," Matthews said.

Committee members pressed staff on where the dataset came from and how the agency determined whether a complaint was anesthesia‑related. Board member Dr. Brian Henderson and others asked whether the investigative form provides clinical detail such as depth of sedation. Staff clarified the dataset came from investigators’ complaint reports and the agency’s case management systems (Versa and PaperVision); those investigator checkboxes and staff entries are the basis of the spreadsheet, not a separate clinical review by the Dental Review Panel. "This is the data that our team puts in, based on the case information they've received," Matthews said.

Committee members also discussed how the data should be published and how much to redact. Legal staff confirmed the rule requires publication of the summary data on the public website; the committee agreed no separate motion was necessary because posting is required. Miss Nichols said staff would coordinate redactions with legal counsel before posting.

The committee spent substantial time on clinical‑practice topics raised by the advisory committee on anesthesia. Members discussed whether the board should publish nonbinding guidance on medical "consults" vs. "clearances" for medically complex patients. Several board members and committee participants — including Dr. Robert McNeil, who is both a physician and a dentist — favored a concise educational piece rather than a regulatory change. "I don't think we need a rule change," Dr. McNeil said, but he supported a short, de‑identified educational statement for licensees and schools. Others agreed the board could author an "opinion/education style" newsletter item and work with legal to avoid creating an unintended mandatory standard.

The committee also revisited monitoring after administration of reversal agents such as flumazenil and naloxone. Members cited the 2018 joint guideline on procedural sedation that recommends monitoring for two hours after antagonists are given. Committee members noted that rule language already requires monitoring until full recovery but does not specify a time interval; some members said a newsletter or guidance could highlight the two‑hour monitoring expectation without converting the guidance into a new, enforceable rule.

Finally, the committee discussed technical improvements to how agency systems exchange records. Matthews told members he will request funding through the next Legislative/Executive Request (LER) for an API to let Versa and PaperVision exchange case information automatically; members also cautioned about using external AI tools because of confidentiality concerns.

The committee concluded by confirming staff will post the de‑identified charts on the public website once legal completes review and redaction, and staff will prepare draft educational language about consults and reversal‑agent monitoring for a future meeting.